Logo-apb
Adv Pharm Bull. 2019;9(3): 360-373. doi: 10.15171/apb.2019.043
PMID: 31592054        PMCID: PMC6773933

Review Article

The Potential of Magnetic Nanoparticles for Diagnosis and Treatment of Cancer Based on Body Magnetic Field and Organ-on-the-Chip

Ali Alirezaie Alavijeh 1 ORCID, Mohammad Barati 2 * ORCID, Meisam Barati 3 ORCID, Hussein Abbasi Dehkordi 1 ORCID

Cited by CrossRef: 25


1- Sharma K, Pathak A, Rawat A, chaubey J, Sharma A, tomar H, singh S. ‘‘Development approach and application of magnetic nanoparticles and encapsulation method’’. Materials Today: Proceedings. 2023; [Crossref]
2- Martín M, Gentili C, Lassalle V. In vitro Biological Tests as the First Tools To Validate Magnetic Nanotheranostics for Colorectal Cancer Models. ChemMedChem. 2020;15(12):1003 [Crossref]
3- Phan K, Ha P, Do H, Nguyen T, Bui T, Pham H, Le M, Le T. Dual Loading of Doxorubicin and Magnetic Iron Oxide into PLA‐TPGS Nanoparticles: Design, in vitro Drug Release Kinetics, and Biological Effects on Cancer Cells. ChemMedChem. 2021;16(23):3615 [Crossref]
4- Khizar S, Ben Halima H, Ahmad N, Zine N, Errachid A, Elaissari A. Magnetic nanoparticles in microfluidic and sensing: From transport to detection. Electrophoresis. 2020;41(13-14):1206 [Crossref]
5- Şen Ö, Emanet M, Ciofani G. Nanotechnology‐Based Strategies to Evaluate and Counteract Cancer Metastasis and Neoangiogenesis. Adv Healthcare Materials. 2021;10(10) [Crossref]
6- Shariati M. The cancer therapy materialization by theranostic nanoparticles based on gold doped iron oxide under electromagnetic field amplification. Nanomedicine: Nanotechnology, Biology and Medicine. 2021;35:102406 [Crossref]
7- Fatima Qizilbash F, Sartaj A, Qamar Z, Kumar S, Imran M, Mohammed Y, Ali J, Baboota S, Ali A. Nanotechnology revolutionises breast cancer treatment: harnessing lipid-based nanocarriers to combat cancer cells. Journal of Drug Targeting. 2023;31(8):794 [Crossref]
8- Khizar S, Ahmad N, Zine N, Jaffrezic-Renault N, Errachid-el-salhi A, Elaissari A. Magnetic Nanoparticles: From Synthesis to Theranostic Applications. ACS Appl Nano Mater. 2021;4(5):4284 [Crossref]
9- Cerqueira M, Belmonte-Reche E, Gallo J, Baltazar F, Bañobre-López M. Magnetic Solid Nanoparticles and Their Counterparts: Recent Advances towards Cancer Theranostics. Pharmaceutics. 2022;14(3):506 [Crossref]
10- Chauhan A, Midha S, Kumar R, Meena R, Singh P, Jha S, Kuanr B. Rapid tumor inhibitionviamagnetic hyperthermia regulated by caspase 3 with time-dependent clearance of iron oxide nanoparticles. Biomater Sci. 2021;9(8):2972 [Crossref]
11- Gimondi S, Ferreira H, Reis R, Neves N. Microfluidic Devices: A Tool for Nanoparticle Synthesis and Performance Evaluation. ACS Nano. 2023;17(15):14205 [Crossref]
12- Monahan D, Almas T, Wyile R, Cheema F, Duffy G, Hameed A. Towards the use of localised delivery strategies to counteract cancer therapy–induced cardiotoxicities. Drug Deliv and Transl Res. 2021;11(5):1924 [Crossref]
13- Martín M, Azcona P, Lassalle V, Gentili C. Doxorubicin delivery by magnetic nanotheranostics enhances the cell death in chemoresistant colorectal cancer-derived cells. European Journal of Pharmaceutical Sciences. 2021;158:105681 [Crossref]
14- Zimina T, Sitkov N, Gareev K, Mikhailova N, Combs S, Shevtsov M. Hybrid-integrated devices for mimicking malignant brain tumors (“tumor-on-a-chip”) for in vitro development of targeted drug delivery and personalized therapy approaches. Front Med. 2024;11 [Crossref]
15- Morey J, Llinás P, Bueno-Costa A, León A, Piña M. Raltitrexed-Modified Gold and Silver Nanoparticles for Targeted Cancer Therapy: Cytotoxicity Behavior In Vitro on A549 and HCT-116 Human Cancer Cells. Materials. 2021;14(3):534 [Crossref]
16- Shivanna A, Dash B, Lu Y, Lin W, Chen J. Magnetic lipid-poly(lactic-co-glycolic acid) nanoparticles conjugated with epidermal growth factor receptor antibody for dual-targeted delivery of CPT-11. International Journal of Pharmaceutics. 2024;667:124856 [Crossref]
17- Almatroudi A. Unlocking the Potential of Silver Nanoparticles: From Synthesis to Versatile Bio-Applications. Pharmaceutics. 2024;16(9):1232 [Crossref]
18- Lemmerman L, Das D, Higuita-Castro N, Mirmira R, Gallego-Perez D. Nanomedicine-Based Strategies for Diabetes: Diagnostics, Monitoring, and Treatment. Trends in Endocrinology & Metabolism. 2020;31(6):448 [Crossref]
19- Eivazzadeh-Keihan R, Gorab M, Aliabadi H, Noruzi E, Kashtiaray A, Bani M, Etminan A, Mirzahoseini H, Cohan R, Maleki A, Mahdavi M. Investigation of biological activity and hyperthermia application of a quaternary magnetic nanobiocomposite based on functionalized carbon nitride nanosheets by carboxymethyl cellulose hydrogel and silk fibroin. Cellulose. 2023;30(5):2997 [Crossref]
20- Sharma S, Kuppusamy G, Chowdhury P, Pamu D. Nanotheranostic Approach for the Management of Colorectal Cancer. NANOASIA. 2024;14(3) [Crossref]
21- Bernad S, Bunge A, Ioncica M, Turcu R, Dan M, Socoliuc V, Susan-Resiga D, Bernad E. Impact of the Different Molecular Weights of Polyethylene Glycol (PEG) Coating Agents on the Magnetic Targeting Characteristics of Functionalized Magnetoresponsive Nanoclusters. Magnetochemistry. 2024;10(7):51 [Crossref]